Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296588082> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4296588082 endingPage "264" @default.
- W4296588082 startingPage "264" @default.
- W4296588082 abstract "<h3>Objective.</h3> —To evaluate the efficacy and safety of ceftriaxone sodium in the treatment of streptococcal endocarditis. <h3>Design.</h3> —An open, multicenter, noncomparative study with a follow-up of patients for 4 months to 5 years. <h3>Setting.</h3> —Internal medicine wards and outpatient clinics of hospitals of various sizes in three European countries. <h3>Patients.</h3> —Fifty-nine patients with defined criteria for streptococcal endocarditis. <h3>Intervention.</h3> —Ceftriaxone sodium administered at a once-daily dose of 2 g for 4 weeks. <h3>Main Outcome Measures.</h3> —Clinical outcome and microbiological cure rate. <h3>Results.</h3> —Among the 59 patients, 55 completed the treatment and were followed up for 4 months to 5 years. No patients showed evidence of relapse. Treatment was completely uneventful in 42 patients (71%). A cardiac valve was replaced in four patients (7%) receiving antimicrobial therapy and in six patients (10%) who had completed antimicrobial therapy. One of the 10 valves taken for culture at surgery was positive, but only for microorganisms that were different from the microorganism isolated before the treatment. The treatment had to be interrupted in four patients because of drug allergy. Other side effects were mild except for two cases of reversible neutropenia. The treatment was easy to administer: 27 patients (46%) had no permanent intravenous catheter at any time, seven patients (12%) had such a catheter for less than 4 days. Twenty-three patients (39%) were discharged from the hospital less than 2 weeks after admission. <h3>Conclusions.</h3> —Ceftriaxone sodium administered at a once-daily dose of 2 g appears to be an effective and safe treatment of streptococcal endocarditis. In hospitals, this agent may be more convenient to administer than penicillin G with or without aminoglycosides. Some patients may even be treated as outpatients. (<i>JAMA</i>. 1992;267:264-267)" @default.
- W4296588082 created "2022-09-22" @default.
- W4296588082 creator A5017600233 @default.
- W4296588082 date "1992-01-08" @default.
- W4296588082 modified "2023-10-04" @default.
- W4296588082 title "Treatment of Streptococcal Endocarditis With a Single Daily Dose of Ceftriaxone Sodium for 4 Weeks" @default.
- W4296588082 doi "https://doi.org/10.1001/jama.1992.03480020074034" @default.
- W4296588082 hasPublicationYear "1992" @default.
- W4296588082 type Work @default.
- W4296588082 citedByCount "82" @default.
- W4296588082 countsByYear W42965880822012 @default.
- W4296588082 countsByYear W42965880822013 @default.
- W4296588082 countsByYear W42965880822014 @default.
- W4296588082 countsByYear W42965880822015 @default.
- W4296588082 countsByYear W42965880822016 @default.
- W4296588082 countsByYear W42965880822017 @default.
- W4296588082 countsByYear W42965880822018 @default.
- W4296588082 countsByYear W42965880822019 @default.
- W4296588082 countsByYear W42965880822020 @default.
- W4296588082 countsByYear W42965880822022 @default.
- W4296588082 countsByYear W42965880822023 @default.
- W4296588082 crossrefType "journal-article" @default.
- W4296588082 hasAuthorship W4296588082A5017600233 @default.
- W4296588082 hasConcept C126322002 @default.
- W4296588082 hasConcept C141071460 @default.
- W4296588082 hasConcept C2775872228 @default.
- W4296588082 hasConcept C2776520383 @default.
- W4296588082 hasConcept C3020110884 @default.
- W4296588082 hasConcept C501593827 @default.
- W4296588082 hasConcept C71924100 @default.
- W4296588082 hasConcept C86803240 @default.
- W4296588082 hasConcept C89423630 @default.
- W4296588082 hasConceptScore W4296588082C126322002 @default.
- W4296588082 hasConceptScore W4296588082C141071460 @default.
- W4296588082 hasConceptScore W4296588082C2775872228 @default.
- W4296588082 hasConceptScore W4296588082C2776520383 @default.
- W4296588082 hasConceptScore W4296588082C3020110884 @default.
- W4296588082 hasConceptScore W4296588082C501593827 @default.
- W4296588082 hasConceptScore W4296588082C71924100 @default.
- W4296588082 hasConceptScore W4296588082C86803240 @default.
- W4296588082 hasConceptScore W4296588082C89423630 @default.
- W4296588082 hasIssue "2" @default.
- W4296588082 hasLocation W42965880821 @default.
- W4296588082 hasOpenAccess W4296588082 @default.
- W4296588082 hasPrimaryLocation W42965880821 @default.
- W4296588082 hasRelatedWork W2003938723 @default.
- W4296588082 hasRelatedWork W2047967234 @default.
- W4296588082 hasRelatedWork W2118496982 @default.
- W4296588082 hasRelatedWork W2364998975 @default.
- W4296588082 hasRelatedWork W2390227121 @default.
- W4296588082 hasRelatedWork W2439875401 @default.
- W4296588082 hasRelatedWork W267745054 @default.
- W4296588082 hasRelatedWork W4231060511 @default.
- W4296588082 hasRelatedWork W4238867864 @default.
- W4296588082 hasRelatedWork W2525756941 @default.
- W4296588082 hasVolume "267" @default.
- W4296588082 isParatext "false" @default.
- W4296588082 isRetracted "false" @default.
- W4296588082 workType "article" @default.